...
首页> 外文期刊>Journal of medical ethics >Needs must: living donor liver transplantation from an HIV-positive mother to her HIV-negative child in Johannesburg, South Africa
【24h】

Needs must: living donor liver transplantation from an HIV-positive mother to her HIV-negative child in Johannesburg, South Africa

机译:需要:在南非约翰内斯堡的艾滋病毒阳性母亲到她的艾滋病毒阴性儿童,生活供体肝移植

获取原文
获取原文并翻译 | 示例

摘要

The world's first living donor liver transplant from an HIV-positive mother to her HIV-negative child, performed by our team in Johannesburg, South Africa (SA) in 2017, was necessitated by disease profile and health system challenges. In our country, we have a major shortage of donor organs, which compels us to consider innovative solutions to save lives. Simultaneously, the transition of the HIV pandemic, from a death sentence to a chronic illness with excellent survival on treatment required us to rethink our policies regarding HIV infection and living donor liver transplantation. Although HIV infection in the donor is internationally considered an absolute contraindication for transplant to an HIV-negative recipient, there have been a very small number of unintentional transplants from HIV-positive deceased donors to HIV-negative recipients. These transplant recipients do well on antiretroviral medication and their graft survival is not compromised. We have had a number of HIV-positive parents in our setting express a desire to be living liver donors for their critically ill children. Declining these parents as living donors has become increasingly unjustifiable given the very small deceased donor pool in SA; and because many of these parents are virally suppressed and would otherwise fulfil our eligibility criteria as living donors. This paper discusses the evolution of HIV and transplantation in SA, highlights some of the primary ethical considerations for us when embarking on this case and considers the new ethical issues that have arisen since we undertook this transplant.
机译:世界上第一个从艾滋病毒阳性母亲移植到2017年约翰内斯堡(SA)在约翰内斯堡的艾滋病病毒阴性儿童移植到她的艾滋病毒阴性儿童,这是疾病概况和卫生系统挑战所必需的。在我国,我们对捐助机构的主要短缺,这迫使我们考虑拯救生命的创新解决方案。同时,HIV大流行的过渡,从死刑判决到慢性疾病,患有良好的治疗生存,要求我们重新思考我们关于艾滋病毒感染和活体肝移植的政策。虽然捐助者的艾滋病毒感染是国际性地被认为对艾滋病毒阴性受体移植的绝对禁忌症,但艾滋病毒阳性死者捐献者对HIV阴性受体有一定程度的无意移植。这些移植受者在抗逆转录病毒药物上做得好,并且它们的移植物存活率不会受到损害。我们在我们的环境中有许多艾滋病毒阳性父母表达了渴望为他们批判性的儿童生活肝脏捐赠者。鉴于SA中的大小死者捐助池,这些父母作为生活捐赠者变得越来越不切实际;因为许多这些父母都是公然抑制的,否则将履行我们的资格标准作为生活捐赠者。本文讨论了SA中艾滋病毒和移植的演变,突出了我们在开始这种情况的开始时为我们的一些主要道德考虑因素,并考虑自从我们进行这种移植以来出现的新道德问题。

著录项

  • 来源
    《Journal of medical ethics 》 |2019年第5期| 共4页
  • 作者单位

    Univ Witwatersrand Donald Gordon Med Ctr Johannesburg Gauteng South Africa;

    Univ Witwatersrand Donald Gordon Med Ctr Johannesburg Gauteng South Africa;

    Univ Witwatersrand Donald Gordon Med Ctr Johannesburg Gauteng South Africa;

    Univ Witwatersrand Fac Hlth Sci Internal Med Johannesburg Gauteng South Africa;

    Natl Inst Communicable Dis Ctr HIV &

    STIs Johannesburg South Africa;

    Univ Witwatersrand Donald Gordon Med Ctr Johannesburg Gauteng South Africa;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号